Biotech · Private company
Nuvig Therapeutics, Inc.
Track this companyFree. Adds Nuvig Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NVG-2089Phase 2 · Chronic Inflammatory Demyelinating PolyneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- NVG-2089Phase 2 · Immune Thrombocytopenia (ITP)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune ThrombocytopeniaPHASE2 · RECRUITING · started Sep 30, 2025ClinicalTrials.gov NCT07095127 · fetched Nov 12, 2026
- Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDPPHASE2 · TERMINATED · started Apr 25, 2025ClinicalTrials.gov NCT07027111 · fetched Nov 12, 2026